Literature DB >> 31115660

Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia.

Isabel Maurus1, Alkomiet Hasan2, Astrid Röh2, Shun Takahashi2,3, Boris Rauchmann2, Daniel Keeser2,4, Berend Malchow5, Andrea Schmitt2,6, Peter Falkai2.   

Abstract

Schizophrenia is a severe neuropsychiatric disease that is associated with neurobiological alterations in multiple brain regions and peripheral organs. Negative symptoms and cognitive deficits are present in about half of patients and are difficult to treat, leading to an unfavorable functional outcome. To investigate the impact of aerobic exercise on various neurobiological parameters, we conducted a narrative review. Add-on aerobic exercise was shown to be effective in improving negative and general symptoms, cognition, global functioning, and quality of life in schizophrenia patients. Based on findings in healthy individuals and animal models, this qualitative review gives an overview of different lines of evidence on how aerobic exercise impacts brain structure and function and molecular mechanisms in patients with schizophrenia and how its effects could be related to clinical and functional outcomes. Structural magnetic resonance imaging studies showed a volume increase in the hippocampus and cortical regions in schizophrenia patients and healthy controls after endurance training. However, results are inconsistent and individual risk factors may influence neuroplastic processes. Animal studies indicate that alterations in epigenetic mechanisms and synaptic plasticity are possible underlying mechanisms, but that differentiation of glial cells, angiogenesis, and possibly neurogenesis may also be involved. Clinical and animal studies also revealed effects of aerobic exercise on the hypothalamus-pituitary-adrenal axis, growth factors, and immune-related mechanisms. Some findings indicate effects on neurotransmitters and the endocannabinoid system. Further research is required to clarify how individual risk factors in schizophrenia patients mediate or moderate the neurobiological effects of exercise on brain and cognition. Altogether, aerobic exercise is a promising candidate in the search for pathophysiology-based add-on interventions in schizophrenia.

Entities:  

Keywords:  Aerobic exercise; Epigenetics; Molecular mechanisms; Neurobiology; Plasticity; Schizophrenia

Mesh:

Year:  2019        PMID: 31115660     DOI: 10.1007/s00406-019-01025-w

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  209 in total

1.  Fitness effects on the cognitive function of older adults: a meta-analytic study.

Authors:  Stanley Colcombe; Arthur F Kramer
Journal:  Psychol Sci       Date:  2003-03

2.  Interactions of IGF-1 with the blood-brain barrier in vivo and in situ.

Authors:  W Pan; A J Kastin
Journal:  Neuroendocrinology       Date:  2000-09       Impact factor: 4.914

Review 3.  Role of serotonin in memory impairment.

Authors:  M C Buhot; S Martin; L Segu
Journal:  Ann Med       Date:  2000-04       Impact factor: 4.709

4.  A review of the role of serotonin receptors in psychiatric disorders.

Authors:  Marie Naughton; Jane B. Mulrooney; Brian E. Leonard
Journal:  Hum Psychopharmacol       Date:  2000-08       Impact factor: 1.672

Review 5.  Brain microdialysis in exercise research.

Authors:  R Meeusen; M F Piacentini; K De Meirleir
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 6.  The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing.

Authors:  W E Sonntag; C Lynch; P Thornton; A Khan; S Bennett; R Ingram
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

7.  Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray.

Authors:  Raffaella Molteni; Zhe Ying; Fernando Gómez-Pinilla
Journal:  Eur J Neurosci       Date:  2002-09       Impact factor: 3.386

8.  Protein synthesis-dependent and -independent regulation of hippocampal synapses by brain-derived neurotrophic factor.

Authors:  N Tartaglia; J Du; W J Tyler; E Neale; L Pozzo-Miller; B Lu
Journal:  J Biol Chem       Date:  2001-08-03       Impact factor: 5.157

9.  Increased expression of vascular endothelial growth factor in human skeletal muscle in response to short-term one-legged exercise training.

Authors:  T Gustafsson; A Knutsson; A Puntschart; L Kaijser; A-C Sandberg Nordqvist; C J Sundberg; E Jansson
Journal:  Pflugers Arch       Date:  2002-08-01       Impact factor: 3.657

Review 10.  Exercise: a behavioral intervention to enhance brain health and plasticity.

Authors:  Carl W Cotman; Nicole C Berchtold
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

View more
  19 in total

1.  Aerobic exercise in mental disorders: from basic mechanisms to treatment recommendations.

Authors:  Andrea Schmitt; Daniela Reich-Erkelenz; Alkomiet Hasan; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08       Impact factor: 5.270

2.  High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial.

Authors:  Gry Bang-Kittilsen; Jens Egeland; Tom Langerud Holmen; Therese Torgersen Bigseth; Eivind Andersen; Jon Mordal; Pål Ulleberg; John Abel Engh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-06       Impact factor: 5.270

3.  Exercise interventions in patients with schizophrenia: inspiration to get fit.

Authors:  Fulvio A Scorza; Antonio-Carlos G de Almeida; Carla A Scorza; Josef Finsterer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-10-28       Impact factor: 5.270

4.  Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Change in Individuals with Schizophrenia.

Authors:  Luz H Ospina; Melanie Wall; Lars F Jarskog; Jacob S Ballon; Joseph McEvoy; Matthew N Bartels; Richard Buchsbaum; Richard P Sloan; T Scott Stroup; David Kimhy
Journal:  J Psychiatr Brain Sci       Date:  2019-12-30

5.  A web-based adapted physical activity program (e-APA) versus health education program (e-HE) in patients with schizophrenia and healthy volunteers: study protocol for a randomized controlled trial (PEPSY V@Si).

Authors:  Maxime Tréhout; Elise Leroux; Lucile Bigot; Solenne Jego; Pascal Leconte; Emmanuel Reboursière; Rémy Morello; Pierre-Alexandre Chapon; Aline Herbinet; Gaëlle Quarck; Sonia Dollfus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-26       Impact factor: 5.270

6.  Schizophrenia Outside the Brain.

Authors:  Aline Gazzola Fragnani Valença; Bradley Joseph Smith
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

7.  Impact of the metabolic syndrome on severe mental disorders.

Authors:  Andrea Schmitt; Daniela Reich-Erkelenz; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-08       Impact factor: 5.270

8.  Differential Physical and Mental Benefits of Physiotherapy Program Among Patients With Schizophrenia and Healthy Controls Suggesting Different Physical Characteristics and Needs.

Authors:  Michele Fonseca Szortyka; Viviane Batista Cristiano; Paulo Belmonte-de-Abreu
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

9.  Enhancement of aerobic fitness improves social functioning in individuals with schizophrenia.

Authors:  D Kimhy; C Tay; J Vakhrusheva; K Beck-Felts; L H Ospina; C Ifrah; M Parvaz; J J Gross; M N Bartels
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-01-03       Impact factor: 5.760

Review 10.  Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?

Authors:  Tomasz Charytoniuk; Hubert Zywno; Karolina Konstantynowicz-Nowicka; Klaudia Berk; Wiktor Bzdega; Adrian Chabowski
Journal:  Int J Mol Sci       Date:  2020-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.